|
POLK expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.981800E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.635400E-01 |
| Normal-vs-Stage2 |
9.351600E-01 |
| Normal-vs-Stage3 |
1.641990E-02 |
| Normal-vs-Stage4 |
8.550200E-04 |
| Stage1-vs-Stage2 |
7.529800E-01 |
| Stage1-vs-Stage3 |
2.564400E-02 |
| Stage1-vs-Stage4 |
8.426400E-04 |
| Stage2-vs-Stage3 |
1.301360E-01 |
| Stage2-vs-Stage4 |
3.387600E-02 |
| Stage3-vs-Stage4 |
3.391400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.912590E-01 |
| Normal-vs-AfricanAmerican |
3.573100E-04 |
| Normal-vs-Asian |
8.039200E-01 |
| Caucasian-vs-AfricanAmerican |
3.160600E-03 |
| Caucasian-vs-Asian |
9.490200E-01 |
| AfricanAmerican-vs-Asian |
2.282800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.692100E-02 |
| Normal-vs-Female |
4.342000E-01 |
| Male-vs-Female |
2.533400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.343100E-03 |
| Normal-vs-Age(41-60Yrs) |
3.073600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.343960E-01 |
| Normal-vs-Age(81-100Yrs) |
9.224500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.093500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.039400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.177600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.438800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.366400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.197600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.866000E-01 |
| Normal-vs-Grade 2 |
8.480400E-01 |
| Normal-vs-Grade 3 |
2.586000E-02 |
| Normal-vs-Grade 4 |
4.47609999998377E-06 |
| Grade 1-vs-Grade 2 |
4.705600E-01 |
| Grade 1-vs-Grade 3 |
1.063800E-01 |
| Grade 1-vs-Grade 4 |
1.957290E-03 |
| Grade 2-vs-Grade 3 |
1.303910E-02 |
| Grade 2-vs-Grade 4 |
1.27400000005107E-06 |
| Grade 3-vs-Grade 4 |
4.443800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.038400E-02 |
| Normal-vs-ccB subtype |
2.617500E-03 |
| ccA subtype-vs-ccB subtype |
2.7424000004217E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.954600E-01 |
| Normal-vs-N1 |
1.582160E-01 |
| N0-vs-N1 |
2.801400E-01 |
|
|
